Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Head Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03416153
What this trial is testing

Individualized Adaptive De-escalated Radiotherapy for HPV-related Oropharynx Cancer

Who this might be right for
Oropharynx Cancer
University of Michigan Rogel Cancer Center 91
Early research (Phase 1)Study completedNCT00004065
What this trial is testing

Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+9 more
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Looking for participantsNCT07040072
What this trial is testing

Finotonlimab Combined With Stapokibart in the Treatment of Recurrent/Metastatic HNSCC

Who this might be right for
HNSCC
Beijing Tongren Hospital 10
Testing effectiveness (Phase 2)Ended earlyNCT04683939
What this trial is testing

Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract Tumors

Who this might be right for
Solid TumorGastric CancerGastroesophageal Junction Adenocarcinoma+5 more
BioNTech SE 13
Testing effectiveness (Phase 2)Active Not RecruitingNCT04868877
What this trial is testing

Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in Combination

Who this might be right for
Non-Small Cell Lung Cancer MetastaticGastric CancerEsophageal Squamous Cell Carcinoma+2 more
Merus B.V. 194
Not applicableUnknownNCT01891123
What this trial is testing

Explore the Individual Treatment of Docetaxel and Paclitaxel in NSCLC, NPC and BRC by PK-guided Dosing Strategy

Who this might be right for
Non-small Cell Lung CancerBreast CancerNasal Cancer
Sun Yat-sen University 300
Testing effectiveness (Phase 2)Ended earlyNCT00551759
What this trial is testing

Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer

Who this might be right for
Esophageal Cancer
Eastern Cooperative Oncology Group 22
Not applicableEnded earlyNCT01053546
What this trial is testing

Effects of Swallowing Exercises on Patients Undergoing Radiation Treatment for Head and Neck Cancer

Who this might be right for
Head and Neck CancerStage I Hypopharyngeal CancerStage I Laryngeal Cancer+10 more
Wake Forest University Health Sciences 14
Testing effectiveness (Phase 2)Ended earlyNCT00765570
What this trial is testing

Study of Advanced Bulky Malignancies With Spatially Fractioned Radiation Therapy

Who this might be right for
Advanced Bulky Malignancies
Summa Health System 12
Large-scale testing (Phase 3)UnknownNCT02048254
What this trial is testing

Study of I-125 Brachytherapy Versus Intensity-modulated Radiation Therapy to Treat Inoperable Salivary Gland Cancer

Who this might be right for
Salivary Gland Cancer
Peking University 90
Large-scale testing (Phase 3)UnknownNCT02111460
What this trial is testing

Chemotherapy Combined With Radiotherapy vs Chemotherapy Alone for Distant Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 126
Testing effectiveness (Phase 2)Study completedNCT01217060
What this trial is testing

Trimodality Management of T1b Esophageal Cancers

Who this might be right for
Esophageal Cancer
M.D. Anderson Cancer Center 4
Testing effectiveness (Phase 2)Ended earlyNCT04928820
What this trial is testing

68Ga-PSMA-11 PET/CT for the Diagnosis of Bone Metastases in Patients With Prostate Cancer and Biochemical Progression During Androgen Deprivation Therapy

Who this might be right for
Biochemically Recurrent Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneMetastatic Prostate Carcinoma+3 more
Jonsson Comprehensive Cancer Center 22
Not applicableLooking for participantsNCT06902623
What this trial is testing

Treatment De-Escalation for Favorable Prognosis Human Papilloma Virus (HPV) or p16-Positive Oropharyngeal Cancer Receiving Definitive Radiotherapy

Who this might be right for
Oropharyngeal CancersHPVTonsil Cancer+1 more
Georgetown University 30
Not applicableStudy completedNCT01110980
What this trial is testing

Normalcy of Food Intake in Head and Neck Cancer Patients

Who this might be right for
Neoplasms, Head and Neck
Radboud University Medical Center 120
Testing effectiveness (Phase 2)Looking for participantsNCT05674396
What this trial is testing

3-5 FrAction Stereotactic Body Radiation Therapy for Palliation of Head and Neck Squamous Cell Carcinoma: the FAST Phase II Randomized Trial

Who this might be right for
Head and Neck Squamous Cell Carcinoma
M.D. Anderson Cancer Center 108
Testing effectiveness (Phase 2)Study completedNCT05156970
What this trial is testing

Camrelizumab in Combination With Chemotherapy or Apatinib Mesylate as First-Line Treatment for R/M HNSCC

Who this might be right for
Recurrent Head and Neck Squamous Cell CarcinomaMetastatic Head and Neck Squamous Cell Carcinoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 81
Testing effectiveness (Phase 2)Active Not RecruitingNCT05237960
What this trial is testing

Metformin for the Prevention of Oral Cancer in Patients With Oral Leukoplakia or Erythroplakia

Who this might be right for
ErythroplakiaOral Leukoplakia
University of Arizona 34
Early research (Phase 1)Ended earlyNCT05427396
What this trial is testing

A Phase I Clinical Study of Recombinant Humanized Anti-BTLA Monoclonal Antibody (JS004) Injection Combined With Toripalimab Injection in Patients With Advanced Solid Tumors

Who this might be right for
Liver Cancer, Esophageal Squamous Cell Carcinoma, Gastric Adenocarcinoma, Cervical Cancer, MSI-H Colorectal Cancer
Shanghai Junshi Bioscience Co., Ltd. 31
Not applicableLooking for participantsNCT06061705
What this trial is testing

Identification of Individual Histological and Blood Markers in Patients With Recurrent or Metastatic Upper Aerodigestive Tract Squamous Cell Carcinoma in Response to Immunotherapies

Who this might be right for
Squamous Cell Carcinoma of the Oropharynx
Fondation Hôpital Saint-Joseph 100
Next Page